Terumo Aortic

What Terumo Aortic does

Terumo Aortic is a UK-headquartered global medical device company that designs, manufactures, and sells implantable devices for the treatment of aortic and peripheral vascular disease, including thoracic and abdominal aortic aneurysms, acute and chronic aortic dissections, and complex aortic arch pathologies. Founded in 1982 and operating from Inchinnan, Scotland, the company is a wholly-owned strategic business unit of Terumo Corporation (TSE: 4543) and runs US operations through Bolton Medical Inc. Its product portfolio covers three therapeutic modalities: surgical grafts (Gelweave woven polyester with cross-linked gelatin sealing, Gelsoft Plus knitted grafts, AQUABRID); endovascular stent-graft systems (TREO abdominal system, RelayPro and RelayPlus thoracic systems); and hybrid devices, most notably Thoraflex Hybrid, the only FDA-approved Frozen Elephant Trunk device for complex aortic arch repair. A Custom Solutions program extends the portfolio with patient-specific devices (Anaconda Custom Made, Fenestrated TREO, RelayBranch, Thoracoflo, Thoraflex Hybrid Custom Made) supported by the AortaFit automated case-planning software acquired from Aortica Corporation.

The underlying technology combines proprietary Gelweave textiles with Nitinol self-expanding stent-grafts, featuring low-profile delivery systems with dual-sheath construction, independent sinusoidal ring-stent designs for anatomic conformity, and dual fixation lock-stent mechanisms. Terumo Aortic sells directly to hospitals and vascular/cardiothoracic surgeons through enterprise field sales in 100+ countries, with regulatory clearances across the FDA, CE Mark, PMDA, and Health Canada frameworks, and reimbursement secured through CMS NTAP plus the newly established MS-DRG 209 for complex aortic arch procedures. The company has invested over £50 million to expand its Renfrewshire manufacturing facility and plans to hire more than 100 new associates, while pursuing multiple FDA Breakthrough Device Designations and pivotal IDE studies (Fenestrated TREO, Rapidlink) to expand indications and geographic reach.

Name

Terumo Aortic

Legal name

Terumo Aortic

Website

https://terumoaortic.com

Company type

Private

Founded year

1982

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Terumo Aortic is a UK-based global medical device company and subsidiary of Terumo Corporation that designs and manufactures surgical grafts, endovascular stent-grafts, and hybrid devices for treating aortic aneurysms, dissections, and complex aortic arch disease, selling directly to hospitals and vascular surgeons in over 100 countries.

Ownership category

akta.pro rank

Product category

Aortic Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Endovascular Aortic Repair (EVAR/TEVAR) & Aortic Grafts (HLAHAFAF)

Keywords

• Aortic stent grafts
• Vascular surgical grafts
• Endovascular aortic repair
• Frozen elephant trunk devices
• Aortic disease treatment

Headquarters

HQ city

Inchinnan

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales: Terumo Aortic generates revenue through the sale of single-use medical devices including surgical grafts, stent-graft systems, and hybrid devices for treating aortic disease. Products are sold directly to hospitals and healthcare providers globally.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels7 records

Core offering

Terumo Aortic manufactures and sells single-use medical devices for the treatment of aortic and peripheral vascular disease, including woven surgical grafts, thoracic and abdominal endovascular stent-graft systems, and hybrid surgical-endovascular devices for complex aortic arch repair. The portfolio also includes a custom-made devices program for patients with unique anatomies, complemented by accessories such as the Aortic Balloon and the AortaFit case-planning software. Products are sold directly to hospitals and healthcare providers globally across more than 100 countries.

Product overview

Terumo Aortic is a global medical device company offering a comprehensive portfolio of surgical, endovascular, and hybrid devices to treat every segment of the aorta. The product portfolio includes three main categories: (1) Surgical Grafts - Gelweave woven grafts and Gelsoft Plus knitted grafts with cross-linked gelatin sealing; (2) Endovascular Stent-Grafts - TREO abdominal system and RelayPro/RelayPlus thoracic systems; (3) Hybrid Devices - Thoraflex Hybrid Frozen Elephant Trunk combining surgical graft with stent technology. Additionally, the Custom Solutions program provides patient-specific custom-made devices including Anaconda, Fenestrated TREO, RelayBranch, and Thoracoflo for complex anatomies not suitable for off-the-shelf products. The portfolio is complemented by surgical accessories like the Aortic Balloon and case planning software AortaFit.

Differentiator

Problem solved

Functional benefit

Products and services

• Gelweave Woven aortic surgical graft made with proprietary medical textiles technology, hand-finished with specialist artisan skill. Features cross-linked gelatin sealing for optimal biodegradation and minimal graft porosity. Includes Gelweave Valsalva and Gelweave Coselli variants for surgical repair of the ascending aorta and arch.
• Gelsoft Plus Knitted aortic surgical graft featuring Köper Knit polyester technology. Designed for abdominal vascular grafts where burst strength matches typical local aortic pressure and improved dilatation rates resist graft aneurysm development.
• AQUABRID Aortic surgical graft product in Terumo Aortic's surgical graft portfolio, used for aortic and peripheral vascular reconstruction.
• RelayPro Low-profile thoracic stent-graft system indicated for all pathologies of the descending thoracic artery including aneurysm, PAU, transection and dissection. Features dual sheath technology, pre-curved nitinol inner catheter, and NBS (non-bare stent) configuration. The only FDA-approved endovascular device for extending Thoraflex Hybrid.
• RelayPlus Thoracic stent-graft system utilizing dual sheath technology and proven stent design for thoracic endovascular aortic repair.
• TREO Three-piece abdominal stent-graft system with dual fixation, lock stent technology, and unique leave-behind sheath. Provides thousands of configurations to address varied patient anatomies. FDA-approved for EVAR treatment of abdominal aortic aneurysms.
• Thoraflex Hybrid Hybrid device combining Gelweave polyester graft with Nitinol self-expanding stent graft. The only FDA-approved Frozen Elephant Trunk (FET) device for complex aortic arch disease treatment. Available in Plexus and Ante-Flo configurations.
• Anaconda Custom Made Custom-made stent-graft system enabling physicians to treat patients with complex anatomies. Features repositionable design, versatile fenestration positioning, and 3D anatomical modeling for case planning.
• Custom TREO Custom-made version of the TREO abdominal stent-graft system tailored to individual patient anatomies.
• Fenestrated TREO Custom fenestrated version of TREO system designed for juxtarenal and suprarenal aortic aneurysms. Features fenestrations for branch vessel preservation. Received FDA Breakthrough Device Designation.
• RelayBranch Custom thoracic stent-graft system with anterograde tunnels for innominate and left common carotid artery coverage. Part of feasibility study in US. Received FDA Breakthrough Device Designation.
• Relay Proximal Scallop Custom Relay solution featuring proximal scallop design for customized aortic arch repair.
• Relay Multi Feature Custom Relay solution with multiple features for complex aortic arch anatomies.
• Thoraflex Hybrid Custom Made Custom-made version of Thoraflex Hybrid device for patients with unique anatomical requirements.
• Thoracoflo Custom-made thoracoabdominal hybrid device combining Gelweave woven polyester grafts with unique ring-stent technology. Used to treat patients with thoracoabdominal aortic disease using less invasive surgical technique than traditional open repair.
• Aortic Balloon Low profile device (10F) with exceptional inflation control and broadest balloon diameter range. Assists physicians in expansion of aorta when using TREO and RELAY stent-grafts in endovascular aortic repair.
• Rapidlink Device designed for repair or replacement of supra-aortic vessels during open surgical repair of aortic disease involving the thoracic aorta. Currently in pivotal IDE study phase.

Quantifiable outcome

• 30-day mortality rate of 5% for Thoraflex Hybrid
• +5 more outcomes

Named customers5 records

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Three partnerships are on record, tiered core and minor.

• BentleycoreStrategic or Co-development Partner · 1 October 2025Clinical study collaboration with Bentley, a leading global manufacturer of balloon-expandable covered stents. The partnership aims to advance FEVAR (Fenestrated Endovascular Aneurysm Repair) procedures through implantation of Terumo Aortic's Fenestrated TREO device combined with Bentley's BeFlared FEVAR Bridging Stent.
• Materialise MedicalminorGTM or Marketing Partner · 20 November 2024Jamie McCarte, Head of Global Custom Devices at Terumo Aortic, appeared on Materialise Medical 3D Players podcast to discuss how personalized solutions are transforming treatment of aortic diseases and the collaboration between engineers and clinicians.
• NAMSAcoreImplementation/ SI/ Consulting Partner · 21 June 2023Strategic outsourcing partnership with NAMSA, a world-leading MedTech Contract Research Organization. NAMSA provides full suite of global development services including preclinical, testing, regulatory, quality, reimbursement, and clinical services to help accelerate commercialization of Terumo Aortic's innovative aortic disease products.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Cook Medical: Cook Medical's Zenith platform (abdominal and thoracic stent-grafts) and custom fenestrated/branched EVAR devices compete directly with Terumo Aortic's TREO, RelayPro, and Custom Solutions portfolio. Cook is particularly strong in the US fenestrated EVAR segment where Terumo Aortic currently cannot compete.
• LeMaitre Vascular: LeMaitre Vascular manufactures vascular grafts and carotid patches used in open aortic and peripheral vascular surgery, directly competing with Terumo Aortic's Gelweave and Gelsoft Plus surgical graft lines. Comparable specialty vascular surgical device company.
• Artivion (formerly CryoLife): Artivion competes directly in aortic stent-grafting through its JOTEC acquisition (now Artivion GmbH) and has overlapping presence in complex aortic repair. Also offers surgical patches and cardiac products that overlap with Terumo Aortic's portfolio.
• W.L. Gore & Associates: Manufacturer of the GORE EXCLUDER abdominal stent-graft and GORE TAG thoracic endograft, Gore is a primary direct competitor in both EVAR and TEVAR. Gore also produces surgical graft materials used by other manufacturers, making it both competitor and potential supplier to the broader aortic space.

Regional players

• MicroPort Scientific: MicroPort's endovascular division produces aortic stent-graft systems primarily serving Asia-Pacific and emerging markets, providing regional competition to Terumo Aortic outside the US/Europe core. Has comparable product lines for thoracic and abdominal aortic repair.

Emerging players

• Bentley: Bentley manufactures balloon-expandable covered stents (BeFlared) used in FEVAR procedures and has an active clinical study collaboration with Terumo Aortic combining Fenestrated TREO with BeFlared bridging stents. Functions as both collaborator and adjacent competitor in the FEVAR ecosystem.
• Penumbra: While primarily known for thrombectomy, Penumbra has been expanding into vascular and aortic applications through product development and acquisitions, representing an emerging competitive threat in the broader endovascular space.

Broad incumbents

• Medtronic: Global medical device leader with the Endurant abdominal stent-graft system and Valiant thoracic stent-graft, making Medtronic one of the largest direct competitors in the EVAR/TEVAR market. Operates across the entire cardiovascular device portfolio with substantially larger scale and US sales infrastructure.
• Getinge: Getinge provides iCast covered stents used as bridging stents in Terumo Aortic's Fenestrated TREO pivotal IDE study, but also competes in cardiac surgery, vascular surgery, and sterile supply categories. The strategic relationship (partner via iCast) coexists with competitive overlap in surgical environments.
• Abbott (Endovascular): Abbott's endovascular division produces peripheral and vascular intervention devices with overlap into aortic disease treatment pathways. As a major diversified medical device incumbent, Abbott competes for hospital contracts and procedural share in the vascular surgery suite.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/TerumoAortic
• YouTubevumedi.com/channel/terumo-aortic
• LinkedInlinkedin.com/company/28630553

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Terumo Aortic